Abstract
Activation of cellular proto-oncogenes as a result of chromosomal abnormalities has been implicated in the development of some human malignancies. Perhaps one of the most striking examples of this association occurs in chronic myelogenous leukaemia, where the Philadelphia (Ph) translocation results in substitution of the 5' end of the c-abl proto-oncogene with ber gene sequences. A unique hybrid bcr-abl message is produced. As the Ph translocation is also present in some patients with acute lymphoblastic leukaemia, we initiated studies to determine if similar genomic events occur in these two different forms of Ph-positive leukaemia. Here we report that the Ph translocation in acute lymphoblasticleukaemia can result in production of a novel aberrant c-abl protein that is distinct from the bcr-abl protein found in Ph-positive chronic myelogenous leukaemia. Our observations suggest that alternative mechanisms of activation of c-abl exist, and may be important in the development of human acute lymphoid rather than chronic myeloid malignancies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nowell, P. C. & Hungerford, D. A. Science 132, 1197–1200 (1960).
Rowley, J. D. A. Rev. Genet. 14, 17–39 (1980).
Rowley, J. D. Nature, 243, 290–293 (1973).
Groffen, J. et al. Cell 36, 93–99 (1984).
Heisterkamp, N. et al. Nature 315, 758–761 (1985).
Heisterkamp, N. et al. Nature 306, 239–242 (1983).
Bartram, C. R. et al. Nature 306, 277–280 (1983).
Shtivelman, E., Lifshitz, B., Gale, R. P. & Canaani, E. Nature 315, 550–554 (1985).
Stam, K. Jr et al. New Engl. J. Med. 313, 23–27 (1985).
Kloetzer, W. et al. Virology 140, 230–238 (1985).
Konopka, J. B., Watanabe, S. M. & Witte, O. N. Cell 37, 1035–1042 (1984).
Konopka, J. B. & Witte, O. N. Molec. cell. Biol. 5, 3116–3123 (1985).
Ben-Neriah, Y., Daley, G. Q., Mes-Masson, A., Wine, O. N. & Baltimore, D. Science 233, 212–214 (1986).
Third International Workshop on Chromosomes in Leukemia, Cancer Genet. Cytogenet. 4, 111–137 (1980–81).
Catovsky, D. et al. Am. J. clin. Path. 72, 736–745 (1979).
Catovsky, D. Br. J. Haemat. 42, 493–498 (1979).
Koeffler, H. P. & Golde, D. New Engl. J. Med. 304, 1201–1209 (1981).
Bollum, F. J. Blood 54, 1203–1206 (1979).
Erikson, J., Martinis, J. & Croce, C. M. Nature 294, 173–175 (1981).
Hieter, P. A., Hollis, G. F., Korsemeyer, S. J., Waldmann, T. A. & Leder, P. Nature 294, 536–540 (1981).
Erikson, J. et al. Proc. natn. Acad. Sci. U.S.A 83, 1807–1811 (1986).
Cooper, J. A. & Hunter, T. Molec. cell. Biol. 1, 165–170 (1981).
De Klein, A. et al. Nature 300, 765–767 (1982).
Rosenberg, N. et al. Proc. natn. Acad. Sci. U.S.A. 72, 1932–1936 (1978).
Abelson, H. T. & Rabstein, L. S. Cancer Res. 30, 2213–22 (1970).
Ben-Neriah, Y., Bernards, A., Paskind, M., Daley, G. Q. & Baltimore, D. Cell 44, 577–585 (1986).
Heisterkamp, N. et al. Nature 315, 758–765 (1985).
Konopka, J. B. & Witte, O. N. Biochim. biophys. Acta 823, 1–18 (1985).
Trujillo, J. M., Cork, A., Ahearn, M. J., Youness, E. L. & McCredie, K. B. Blood 53, 695–706 (1979).
Wong-Staal, F., Reitz, M. S. & Gallo, R. C. Proc. natn. Acad. Sci. U.S.A. 76, 2032–36 (1979).
Southern, E. M. J. molec. Biol. 98, 503–507 (1975).
Chou, P. & Fasman, G. D. Adv. Enzym. 47, 45–147 (1978).
Laemmli, U. Nature 227, 68–72 (1970).
Chergwin, J. M., Przybyla, A. E., MacDonald, R. J., Rutter, W. J. Biochemistry, 18, 5294–5298 (1979).
Thomas, P. S. Proc. natn. Acad. Sci. U.S.A. 77, 5201–5206 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kurzrock, R., Shtalrid, M., Romero, P. et al. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 325, 631–635 (1987). https://doi.org/10.1038/325631a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/325631a0
This article is cited by
-
Insights into the prenatal origin of childhood acute lymphoblastic leukemia
Cancer and Metastasis Reviews (2020)
-
Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice
Oncogene (2007)
-
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia
Nature Medicine (2005)
-
Quantification of minimal residual disease in patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay
Leukemia (2002)
-
p38 MAPK-mediated activation of NF-κB by the RhoGEF domain of Bcr
Oncogene (2002)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
